David J. Borges - 12 Jan 2026 Form 4 Insider Report for OMEROS CORP (OMER)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
14 Jan 2026, 17:25:24 UTC
Prior SEC filing
01 Jul 2025
Next SEC filing
24 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Peter B. Cancelmo, Attorney-in-Fact

Key filing fact

David J. Borges filed Form 4 for OMEROS CORP (OMER) on 14 Jan 2026.

Key facts

  • This page summarizes David J. Borges's Form 4 filing for OMEROS CORP (OMER).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 14 Jan 2026, 17:25.

Change

  • Previous filing in this sequence was filed on 01 Jul 2025.
  • Current net transaction value: -$659,115.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002005787 Primary reporting owner

Borges David J.

Relationship
VP, Finance & CAO
Address
201 ELLIOTT AVENUE WEST, SEATTLE
Signature
/s/ Peter B. Cancelmo, Attorney-in-Fact
Signature date
14 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OMER transaction

Common stock

Sale

Transaction value
$381,600
Shares
-30,000
Change %
-100%
Price
$12.72
Shares after
0
Date
12 Jan 2026
Ownership
Direct
Footnotes
F1
OMER transaction

Common stock

Options Exercise

Transaction value
$91,800
Shares
+30,000
Change %
Price
$3.06
Shares after
30,000
Date
13 Jan 2026
Ownership
Direct
OMER transaction

Common stock

Sale

Transaction value
$369,315
Shares
-30,000
Change %
-100%
Price
$12.31
Shares after
0
Date
13 Jan 2026
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OMER transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-30,000
Change %
-32%
Price
$0.000000
Shares after
65,000
Date
13 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
30,000
Exercise price
$3.06
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

This transaction was executed in multiple trades at prices ranging from $12.56 to $13.06. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Footnote F2

This transaction was executed in multiple trades at prices ranging from $12.13 to $12.62. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Footnote F3

This option vests and becomes exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2024. Installments vest and become exercisable on each monthly anniversary thereafter.

SEC remarks

The reporting person has completed all currently planned sales of Omeros Corporation's common stock.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .